Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPSCAR: Topical CBD for Paramedian Forehead Flap Scar Healing
NCT06129591Phase 1Recruiting
- Sponsor
- University of Oklahoma
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Zygel in scar (2 arms), sponsored by University of Oklahoma. Primary endpoint: Assessment of subjective and objective effects of CBD on the outcomes of healing scars at 2 years. Started Sep 2026; status: recruiting.
02
Drugs
Zygel
03
Conditions
scar
Beyond the preview
Go deeper on NCT06129591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06129591.